AU2003294396A1 - Tocopherol and tocotrienol medicaments - Google Patents
Tocopherol and tocotrienol medicamentsInfo
- Publication number
- AU2003294396A1 AU2003294396A1 AU2003294396A AU2003294396A AU2003294396A1 AU 2003294396 A1 AU2003294396 A1 AU 2003294396A1 AU 2003294396 A AU2003294396 A AU 2003294396A AU 2003294396 A AU2003294396 A AU 2003294396A AU 2003294396 A1 AU2003294396 A1 AU 2003294396A1
- Authority
- AU
- Australia
- Prior art keywords
- tocotrienol
- tocopherol
- medicaments
- tocotrienol medicaments
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- GJJVAFUKOBZPCB-UHFFFAOYSA-N 2-methyl-2-(4,8,12-trimethyltrideca-3,7,11-trienyl)-3,4-dihydrochromen-6-ol Chemical compound OC1=CC=C2OC(CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-UHFFFAOYSA-N 0.000 title 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229930003799 tocopherol Natural products 0.000 title 1
- 239000011732 tocopherol Substances 0.000 title 1
- 229960001295 tocopherol Drugs 0.000 title 1
- 235000010384 tocopherol Nutrition 0.000 title 1
- 229930003802 tocotrienol Natural products 0.000 title 1
- 239000011731 tocotrienol Substances 0.000 title 1
- 235000019148 tocotrienols Nutrition 0.000 title 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/301,211 US20040102421A1 (en) | 2002-11-21 | 2002-11-21 | Tocopherol and tocotrienol anti-inflammatory medicaments |
| US10/301,211 | 2002-11-21 | ||
| US10/304,918 US7399784B2 (en) | 2002-11-26 | 2002-11-26 | Tocopherol and tocotrienol anti-obesity medicaments |
| US10/304,918 | 2002-11-26 | ||
| PCT/US2003/037135 WO2004047732A2 (en) | 2002-11-21 | 2003-11-19 | Tocopherol and tocotrienol medicaments |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2003294396A8 AU2003294396A8 (en) | 2004-06-18 |
| AU2003294396A1 true AU2003294396A1 (en) | 2004-06-18 |
Family
ID=32396699
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003294396A Abandoned AU2003294396A1 (en) | 2002-11-21 | 2003-11-19 | Tocopherol and tocotrienol medicaments |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2003294396A1 (en) |
| WO (1) | WO2004047732A2 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8952000B2 (en) | 2011-02-16 | 2015-02-10 | Pivotal Therapeutics Inc. | Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events |
| US8951514B2 (en) | 2011-02-16 | 2015-02-10 | Pivotal Therapeutics Inc. | Statin and omega 3 fatty acids for reduction of apolipoprotein-B levels |
| US9119826B2 (en) | 2011-02-16 | 2015-09-01 | Pivotal Therapeutics, Inc. | Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levels |
| US8715648B2 (en) | 2011-02-16 | 2014-05-06 | Pivotal Therapeutics Inc. | Method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (CVD) and diabetics |
| CN114712514B (en) * | 2022-03-03 | 2023-03-31 | 浙江大学 | Nanometer medicinal preparation for reducing blood fat locally and systemically, and its application |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1289091C (en) * | 1998-02-11 | 2006-12-13 | Rtp药品公司 | Method and composition for treatment of inflammatory conditions |
| US6761903B2 (en) * | 1999-06-30 | 2004-07-13 | Lipocine, Inc. | Clear oil-containing pharmaceutical compositions containing a therapeutic agent |
| US20030007961A1 (en) * | 2001-06-22 | 2003-01-09 | Wilburn Michael D. | Orthomolecular vitamin E derivatives |
| MXPA04001555A (en) * | 2001-08-21 | 2004-10-27 | Galileo Pharmaceuticals Inc | Tocopherol enriched compositions and amelioration of inflammatory symptoms. |
| AU2002352726A1 (en) * | 2001-11-15 | 2003-06-10 | Galileo Laboratories, Inc. | Formulations and methods for treatment or amelioration of inflammatory conditions |
-
2003
- 2003-11-19 AU AU2003294396A patent/AU2003294396A1/en not_active Abandoned
- 2003-11-19 WO PCT/US2003/037135 patent/WO2004047732A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003294396A8 (en) | 2004-06-18 |
| WO2004047732A2 (en) | 2004-06-10 |
| WO2004047732A3 (en) | 2004-08-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003266321A1 (en) | Tetrahydropyrimidine-2-one derivatives and their uses | |
| AU2002365120A1 (en) | Medicaments | |
| AUPR846401A0 (en) | 6-Hydroxy isoflavones, derivatives and medicaments involving same | |
| EP1556031A4 (en) | Chromones and chromone derivatives and uses thereof | |
| AU2002353971A1 (en) | Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof | |
| AU2002326312A1 (en) | Cannabinoids | |
| AU2002952453A0 (en) | Aminated isoflavonoid derivatives and uses thereof | |
| AU2003268083A1 (en) | Tocopherol biosynthesis related genes and uses thereof | |
| AU2002351764A1 (en) | Flavonoid compounds and their pharmaceutical uses | |
| AU2003228400A1 (en) | Medicant package | |
| AU2003301968A1 (en) | 4-aminomethyl-1-aryl-cyclohexylamine derivatives | |
| AU2003278369A1 (en) | 3-cyano-quinoline derivatives | |
| AU2003250401A1 (en) | Flower essence-containing medicaments | |
| AU2003296564A1 (en) | 4-hydroxymethyl-1-aryl-cyclohexylamine derivatives | |
| AU2003222659A1 (en) | 23-o-substituted 5-o-mycaminosyltylonide derivatives | |
| AU2003234131A1 (en) | 5-o-mycaminosyltylonide derivatives | |
| AU2003294396A1 (en) | Tocopherol and tocotrienol medicaments | |
| AU2002253441A1 (en) | Medicaments containing glycerophosphoinositol-4-phosphate derivatives | |
| AU2003900495A0 (en) | Aroylhydrazone derivatives and therapeutic uses thereof | |
| AU2002308105A1 (en) | Benzoaxathiepin derivatives and their use as medicines | |
| AU2003241429A1 (en) | 4-thio coumarins | |
| AU2003273398A1 (en) | Aroyl-piperidine derivatives | |
| AU2002249639A1 (en) | Pyranocoumarin derivatives | |
| AU2003238180A1 (en) | 2-naphtamide derivatives | |
| AU2003288012A1 (en) | Isothiazolyl-benzoxazine derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |